{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:47:02Z","timestamp":1781246822838,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021546","name":"Suez University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021546","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) therapy is utilized for chronic tenosynovitis to reduce inflammation and promote tendon sheath repair. This study compared the temporal kinetics of PRP-derived growth factors with clinical outcomes of PRP versus saline injection over 3 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In a randomized controlled trial, 200 patients with chronic tenosynovitis were assigned to non-activated PRP (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009100) or saline (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009100) tendon sheath injection. PRP group blood samples were collected at 1\u00a0h, 8\u00a0h, Days 1, 3, 7, 14, and 1 month post-injection; both groups had clinical and ultrasound assessments at 1 and 3 months. Serum VEGF, PDGF-AB, EGF, and TGF-\u03b2 were quantified via ELISA, with platelet counts analyzed. Pain (VAS), function (WOMAC, DASH), and tendon sheath thickness were evaluated. Repeated-measures ANOVA and t-tests assessed changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the PRP group, non-activated PRP achieved a platelet concentration of 1030\u2009\u00b1\u2009130\u2009\u00d7\u200910\u00b3\/\u00b5L (4.5\u00d7 baseline), and biomarkers varied significantly (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). VEGF peaked at Day 14 (285.44\u2009\u00b1\u200950.0 pg\/mL), sustained at 260.0\u2009\u00b1\u200945.0 pg\/mL (1 month). PDGF-AB peaked at 8\u00a0h (1253.28\u2009\u00b1\u2009160.0 pg\/mL), declining to 300.0\u2009\u00b1\u200990.0 pg\/mL (1 month). EGF peaked at Day 7 (451.84\u2009\u00b1\u200975.0 pg\/mL), returning to 380.0\u2009\u00b1\u200975.0 pg\/mL (1 month). TGF-\u03b2 exhibited plateau kinetics without a distinct peak, stabilizing at 8.50\u2009\u00b1\u20091.80 ng\/mL (1 month). PRP outperformed saline in pain (\u2212\u200950.0\u00a0mm vs. \u221231.0\u00a0mm), function (QuickDASH \u2212\u200935.0 vs. \u221221.0), and sheath thickness reduction (\u2212\u20090.9\u00a0mm vs. \u22120.4\u00a0mm) at 3 months (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). PRP reduced VAS by 57% (30.0\u2009\u00b1\u200911.0\u00a0mm), WOMAC by 42% (35.0\u2009\u00b1\u20097.5), DASH by 38% (40.0\u2009\u00b1\u20099.5), and thickness by 45% (1.54\u2009\u00b1\u20090.30\u00a0mm) at 1 month; by 3 months, VAS was 20.0\u2009\u00b1\u20099.0\u00a0mm, WOMAC 25.0\u2009\u00b1\u20096.5, DASH 30.0\u2009\u00b1\u20097.5, thickness 1.40\u2009\u00b1\u20090.28\u00a0mm (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Saline reduced VAS by 30% (50.0\u2009\u00b1\u200914.0\u00a0mm), WOMAC by 26% (45.0\u2009\u00b1\u20099.5), DASH by 24% (50.0\u2009\u00b1\u200910.5), thickness by 30% (1.99\u2009\u00b1\u20090.38\u00a0mm) at 1 month; by 3 months, VAS was 40.0\u2009\u00b1\u200911.0\u00a0mm, WOMAC 40.0\u2009\u00b1\u20098.5, DASH 45.0\u2009\u00b1\u20099.5, thickness 1.85\u2009\u00b1\u20090.35\u00a0mm (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). PRP outperformed saline (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Adverse events were mild (15% PRP, 7% saline).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Non-activated PRP induces time-specific growth factor release, outperforming saline in 3-month pain, function, and tendon thickness outcomes for tenosynovitis. The larger sample size enhances generalizability, aligning with recommendations for robust musculoskeletal trials and refuting claims of PRP equivalence to placebo. These findings guide PRP timing and support its efficacy over placebo. They also underscore the importance of individualized PRP dosing strategies based on platelet concentration thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      In the Pan African Clinical Trials Registry (PACTR202506613254896) on 10 June 2025, and is accessible at:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=34788\" ext-link-type=\"uri\">https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=34788<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-025-09339-8","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T07:39:01Z","timestamp":1764574741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Time-dependent growth factor kinetics, platelet concentration, and clinical response following platelet-rich plasma versus saline in chronic tenosynovitis: a randomized controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Asmaa E.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai M.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-0035","authenticated-orcid":false,"given":"Amira A.A.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Nosair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia E.","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahled","family":"Esmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Darweash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"1suppl","key":"9339_CR1","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1177\/1947603520931170","volume":"13","author":"G Filardo","year":"2021","unstructured":"Filardo G, Previtali D, Napoli F, Candrian C, Zaffagnini S, Grassi A. PRP injections for the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Cartilage. 2021;13(1suppl):S364-75.","journal-title":"Cartilage"},{"issue":"11","key":"9339_CR2","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1177\/0363546509349921","volume":"37","author":"TE Foster","year":"2009","unstructured":"Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259\u201372.","journal-title":"Am J Sports Med"},{"issue":"3","key":"9339_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.arthro.2011.10.018","volume":"28","author":"SG Boswell","year":"2012","unstructured":"Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2012;28(3):429\u201339.","journal-title":"Arthroscopy: The Journal of Arthroscopic & Related Surgery"},{"issue":"4","key":"9339_CR4","doi-asserted-by":"publisher","first-page":"4823829","DOI":"10.21037\/apm-20-2223","volume":"10","author":"Y Cao","year":"2021","unstructured":"Cao Y, Zhu X, Zhou R, He Y, Wu Z, Chen Y. A narrative review of the research progress and clinical application of platelet-rich plasma. Annals Palliat Med. 2021;10(4):4823829\u20134829.","journal-title":"Annals Palliat Med"},{"issue":"01","key":"9339_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1160\/TH03-07-0440","volume":"91","author":"E Anitua","year":"2004","unstructured":"Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(01):4\u201315.","journal-title":"Thromb Haemost"},{"key":"9339_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2165\/00007256-200939050-00002","volume":"39","author":"M S\u00e1nchez","year":"2009","unstructured":"S\u00e1nchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 2009;39:345\u201354.","journal-title":"Sports Med"},{"issue":"1","key":"9339_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.csm.2008.08.007","volume":"28","author":"A Mishra","year":"2009","unstructured":"Mishra A, Woodall J Jr, Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2009;28(1):113\u201325.","journal-title":"Clin Sports Med"},{"issue":"3","key":"9339_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12178-008-9032-5","volume":"1","author":"S Sampson","year":"2008","unstructured":"Sampson S, Gerhardt M, Mandelbaum B. Platelet-rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1(3):165\u201374.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"20","key":"9339_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2106\/JBJS.16.01374","volume":"99","author":"J Chahla","year":"2017","unstructured":"Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg. 2017;99(20):1769\u201379.","journal-title":"J Bone Joint Surg"},{"issue":"5","key":"9339_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/09537104.2015.1131253","volume":"27","author":"G Eren","year":"2016","unstructured":"Eren G, G\u00fcrkan A, Atmaca H, D\u00f6nmez A, Atilla G. Effect of centrifugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product. Platelets. 2016;27(5):427\u201332.","journal-title":"Platelets"},{"issue":"6","key":"9339_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.exer.2003.08.010","volume":"77","author":"JT Daniels","year":"2003","unstructured":"Daniels JT, Geerling G, Alexander RA, Murphy G, Khaw PT, Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res. 2003;77(6):653\u201364.","journal-title":"Exp Eye Res"},{"issue":"4","key":"9339_CR12","first-page":"S53","volume":"7","author":"K Mautner","year":"2015","unstructured":"Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, Bowen JE. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM&R. 2015;7(4):S53\u201359.","journal-title":"PM&R"},{"issue":"3","key":"9339_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","volume":"27","author":"DM Ehrenfest","year":"2009","unstructured":"Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158\u201367.","journal-title":"Trends Biotechnol"},{"issue":"8","key":"9339_CR14","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1177\/0363546512452713","volume":"40","author":"AD Mazzocca","year":"2012","unstructured":"Mazzocca AD, McCarthy MB, Chowaniec DM, Dugdale EM, Hansen D, Cote MP, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med. 2012;40(8):1742\u20139.","journal-title":"Am J Sports Med"},{"key":"9339_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43161-021-00025-z","volume":"26","author":"W Abu-Taleb","year":"2021","unstructured":"Abu-Taleb W, Rehan Youssef A. Work-related musculoskeletal disorders among Egyptian physical therapists. Bull Fac Phys Therapy. 2021;26:1\u20131.","journal-title":"Bull Fac Phys Therapy"},{"key":"9339_CR16","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00784-016-1719-1","volume":"20","author":"E Kobayashi","year":"2016","unstructured":"Kobayashi E, Fl\u00fcckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Invest. 2016;20:2353\u201360.","journal-title":"Clin Oral Invest"},{"issue":"5","key":"9339_CR17","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s11999-015-4192-2","volume":"473","author":"MO Sch\u00e4r","year":"2015","unstructured":"Sch\u00e4r MO, Diaz-Romero J, Kohl S, Zumstein MA, Nesic D. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro. Clin Orthop Relat Res. 2015;473(5):1635\u201343.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"9339_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5152\/eurjrheum.2015.0032","volume":"4","author":"A Turan","year":"2016","unstructured":"Turan A, \u00c7eltik\u00e7i P, Tufan A, \u00d6zt\u00fcrk MA. Basic radiological assessment of synovial diseases: a pictorial essay. Eur J Rheumatol. 2016;4(2):166.","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"9339_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21315\/mjms2021.28.1.5","volume":"28","author":"D Chenna","year":"2021","unstructured":"Chenna D, Shastry S, Das S. Cocktail protocol for preparation of platelet-rich fibrin glue for autologous use. Malays J Med Sci. 2021;28(1):35.","journal-title":"Malays J Med Sci"},{"issue":"11","key":"9339_CR20","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1177\/0363546513496542","volume":"41","author":"S Kesikburun","year":"2013","unstructured":"Kesikburun S, Tan AK, Yilmaz B, Ya\u015far E, Yazicio\u011flu K. Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up. Am J Sports Med. 2013;41(11):2609\u201316.","journal-title":"Am J Sports Med"},{"issue":"9","key":"9339_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/pmrj.12347","volume":"12","author":"C Townsend","year":"2020","unstructured":"Townsend C, Von Rickenbach KJ, Bailowitz Z, Gellhorn AC. Post-procedure protocols following platelet\u2010rich plasma injections for tendinopathy: a systematic review. PM&R. 2020;12(9):904\u201315.","journal-title":"PM&R"},{"issue":"1","key":"9339_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/ard.2004.022905","volume":"64","author":"F Townsend","year":"2005","unstructured":"Townsend F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant changes in patient-reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29\u201333.","journal-title":"Ann Rheum Dis"},{"key":"9339_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40634-019-0175-7","volume":"6","author":"Y Taniguchi","year":"2019","unstructured":"Taniguchi Y, Yoshioka T, Sugaya H, Gosho M, Aoto K, Kanamori A, et al. Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population. J Exp Orthop. 2019;6:1\u20138.","journal-title":"J Exp Orthop"},{"issue":"31","key":"9339_CR24","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1016\/j.biomaterials.2007.06.037","volume":"28","author":"E Anitua","year":"2007","unstructured":"Anitua E, S\u00e1nchez M, Orive G, And\u00eda I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28(31):4551\u201360.","journal-title":"Biomaterials"},{"issue":"7","key":"9339_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","volume":"28","author":"JM DeLong","year":"2012","unstructured":"DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy: J Arthroscopic Relat Surg. 2012;28(7):998\u20131009.","journal-title":"Arthroscopy: J Arthroscopic Relat Surg"},{"key":"9339_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104593","volume":"82","author":"S Muthu","year":"2022","unstructured":"Muthu S, Krishnan A, Ramanathan KR. Standardization and validation of a conventional high-yield platelet-rich plasma preparation protocol. Ann Med Surg. 2022;82:104593.","journal-title":"Ann Med Surg"},{"issue":"3","key":"9339_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.patbio.2009.04.007","volume":"59","author":"JF Kaux","year":"2011","unstructured":"Kaux JF, Le Goff C, Seidel L, P\u00e9ters P, Gothot A, Albert A, Crielaard JM. Comparative study of five techniques of Preparation of platelet-rich plasma (platelet-rich plasma). Pathol Biol (Paris). 2011;59(3):157\u201360.","journal-title":"Pathol Biol (Paris)"},{"issue":"3","key":"9339_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.21608\/smj.2019.15272.1025","volume":"23","author":"BE Hussien","year":"2019","unstructured":"Hussien BE, Hamed EO, Abd Elwahed SA, Aziz SP, Ahmed NM, Rashed SA. The clinical applications of Platelet-Rich plasma. Sohag Med J. 2019;23(3):186\u201394.","journal-title":"Sohag Med J"},{"issue":"3","key":"9339_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/19476035221118419","volume":"13","author":"Y Liang","year":"2022","unstructured":"Liang Y, Li J, Wang Y, He J, Chen L, Chu J, et al. Platelet rich plasma in the repair of articular cartilage injury: a narrative review. Cartilage. 2022;13(3):19476035221118419.","journal-title":"Cartilage"},{"issue":"1","key":"9339_CR30","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7066090","volume":"2016","author":"C Cavallo","year":"2016","unstructured":"Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, et al. Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed Res Int. 2016;2016(1):6591717.","journal-title":"Biomed Res Int"},{"issue":"6","key":"9339_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/0363546512442924","volume":"40","author":"SA Rodeo","year":"2012","unstructured":"Rodeo SA, Delos D, Williams RJ, Adler RS, Pearle A, Warren RF. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am J Sports Med. 2012;40(6):1234\u201341.","journal-title":"Am J Sports Med"},{"issue":"2","key":"9339_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1051\/ject\/200638174","volume":"38","author":"PA Everts","year":"2006","unstructured":"Everts PA, Knape JT, Weibrich G, Sch\u00f6nberger JP, Hoffmann J, Overdevest EP, Box HA, Van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extracorpor Technol. 2006;38(2):174\u201387.","journal-title":"J Extracorpor Technol"},{"key":"9339_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1250533","volume":"11","author":"M Lin","year":"2023","unstructured":"Lin M, Li W, Ni X, Sui Y, Li H, Chen X, et al. Growth factors in the treatment of Achilles tendon injury. Front Bioeng Biotechnol. 2023;11:1250533.","journal-title":"Front Bioeng Biotechnol"},{"issue":"6","key":"9339_CR34","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/0363546512442334","volume":"40","author":"JL Dragoo","year":"2012","unstructured":"Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med. 2012;40(6):1274\u201381.","journal-title":"Am J Sports Med"},{"issue":"03","key":"9339_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.11138\/jts\/2013.1.3.112","volume":"1","author":"G Filardo","year":"2013","unstructured":"Filardo G, Kon E, Di Matteo B, Di Marino A, Sessa A, Merli ML, Marcacci M. Leukocyte-poor PRP application for the treatment of knee osteoarthritis. Joints. 2013;1(03):112\u201320.","journal-title":"Joints"},{"issue":"12","key":"9339_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","volume":"9","author":"I Andia","year":"2013","unstructured":"Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"9339_CR37","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jor.22869","volume":"33","author":"N Andarawis-Puri","year":"2015","unstructured":"Andarawis-Puri N, Flatow EL, Soslowsky LJ. Tendon basic science: development, repair, regeneration, and healing. J Orthop Res. 2015;33(6):780\u20134.","journal-title":"J Orthop Res"},{"issue":"10","key":"9339_CR38","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/jor.23516","volume":"35","author":"DC Sarver","year":"2017","unstructured":"Sarver DC, Kharaz YA, Sugg KB, Gumucio JP, Comerford E, Mendias CL. Sex differences in tendon structure and function. J Orthop Res. 2017;35(10):2117\u201326.","journal-title":"J Orthop Res"},{"issue":"19","key":"9339_CR39","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.L.00019","volume":"94","author":"TM McCarrel","year":"2012","unstructured":"McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg. 2012;94(19):e143.","journal-title":"J Bone Joint Surg"},{"issue":"2","key":"9339_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/23259671211066504","volume":"10","author":"KN Kunze","year":"2022","unstructured":"Kunze KN, Pakanati JJ, Vadhera AS, Polce EM, Williams BT, Parvaresh KC, et al. The efficacy of platelet-rich plasma for ligament injuries: a systematic review of basic science literature with protocol quality assessment. Orthop J Sports Med. 2022;10(2):23259671211066504.","journal-title":"Orthop J Sports Med"},{"key":"9339_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-021-00783-2","volume":"19","author":"L Fang","year":"2021","unstructured":"Fang L, Gao Y, Wang Z, Li Y, Yan Y, Wu Z, et al. EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression. Cell Commun Signal. 2021;19:1\u20133.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"9339_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jor.21046","volume":"28","author":"J Zhang","year":"2010","unstructured":"Zhang J, Wang JH. Mechanobiological response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy. J Orthop Res. 2010;28(5):639\u201343.","journal-title":"J Orthop Res"},{"key":"9339_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.766080","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X, Zhu B, Li Y, Liu X, Guo S, Wang C, et al. The role of vascular endothelial growth factor in tendon healing. Front Physiol. 2021;12:766080.","journal-title":"Front Physiol"},{"issue":"9","key":"9339_CR44","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1111\/iwj.14261","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li J. Current progress in growth factors and extracellular vesicles in tendon healing. Int Wound J. 2023;20(9):3871\u201383.","journal-title":"Int Wound J"},{"key":"9339_CR45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51779","volume":"9","author":"DA Kaji","year":"2020","unstructured":"Kaji DA, Howell KL, Balic Z, Hubmacher D, Huang AH. Tgf\u03b2 signaling is required for tenocyte recruitment and functional neonatal tendon regeneration. Elife. 2020;9:e51779.","journal-title":"Elife"},{"issue":"6","key":"9339_CR46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/jor.22806","volume":"33","author":"S Thomopoulos","year":"2015","unstructured":"Thomopoulos S, Parks WC, Rifkin DB, Derwin KA. Mechanisms of tendon injury and repair. J Orthop Res. 2015;33(6):832\u20139.","journal-title":"J Orthop Res"},{"issue":"1","key":"9339_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep43301","volume":"7","author":"Z Xu","year":"2017","unstructured":"Xu Z, Yin W, Zhang Y, Qi X, Chen Y, Xie X, et al. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration. Sci Rep. 2017;7(1):43301.","journal-title":"Sci Rep"},{"issue":"2","key":"9339_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11420-011-9239-7","volume":"8","author":"BC Halpern","year":"2012","unstructured":"Halpern BC, Chaudhury S, Rodeo SA. The role of platelet-rich plasma in inducing musculoskeletal tissue healing. HSS Journal\u00ae: The Musculoskeletal Journal of Hospital for Special Surgery. 2012;8(2):137\u201345.","journal-title":"HSS Journal\u00ae: The Musculoskeletal Journal of Hospital for Special Surgery"},{"issue":"5","key":"9339_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12051055","volume":"12","author":"K Florek","year":"2024","unstructured":"Florek K, Mendyka D, Gomu\u0142ka K. Vascular endothelial growth factor (VEGF) and its role in the cardiovascular system. Biomedicines. 2024;12(5):1055.","journal-title":"Biomedicines"},{"key":"9339_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115301","volume":"166","author":"N Beheshtizadeh","year":"2023","unstructured":"Beheshtizadeh N, Gharibshahian M, Bayati M, Maleki R, Strachan H, Doughty S, et al. Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine. Biomed Pharmacother. 2023;166:115301.","journal-title":"Biomed Pharmacother"},{"key":"9339_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.852795","volume":"13","author":"J Lu","year":"2022","unstructured":"Lu J, Jiang L, Chen Y, Lyu K, Zhu B, Li Y, et al. The functions and mechanisms of basic fibroblast growth factor in tendon repair. Front Physiol. 2022;13:852795.","journal-title":"Front Physiol"},{"issue":"5","key":"9339_CR52","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/17453670610013033","volume":"77","author":"O Virchenko","year":"2006","unstructured":"Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006;77(5):806\u201312.","journal-title":"Acta Orthop"},{"issue":"2","key":"9339_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik A, Genov\u00e9 G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011;21(2):193\u2013215.","journal-title":"Dev Cell"},{"issue":"5","key":"9339_CR54","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nm848","volume":"9","author":"R Cao","year":"2003","unstructured":"Cao R, Br\u00e5kenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9(5):604\u201313.","journal-title":"Nat Med"},{"issue":"3","key":"9339_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030434","volume":"11","author":"V Russo","year":"2022","unstructured":"Russo V, El Khatib M, Prencipe G, Citeroni MR, Faydaver M, Mauro A, et al. Tendon immune regeneration: insights on the synergetic role of stem and immune cells during tendon regeneration. Cells. 2022;11(3):434.","journal-title":"Cells"},{"issue":"1","key":"9339_CR56","volume":"2021","author":"F Yang","year":"2021","unstructured":"Yang F, Richardson DW. Comparative analysis of tenogenic gene expression in tenocyte-derived induced pluripotent stem cells and bone marrow\u2010derived mesenchymal stem cells in response to biochemical and biomechanical stimuli. Stem Cells Int. 2021;2021(1):8835576.","journal-title":"Stem Cells Int"},{"issue":"1","key":"9339_CR57","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1515\/med-2016-0048","volume":"11","author":"V Pavlovic","year":"2016","unstructured":"Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet-rich plasma: a short overview of certain bioactive components. Open Med. 2016;11(1):242\u20137.","journal-title":"Open Med"},{"issue":"10","key":"9339_CR58","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","volume":"39","author":"EA Sundman","year":"2011","unstructured":"Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135\u201340.","journal-title":"Am J Sports Med"},{"issue":"1","key":"9339_CR59","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/2860547","volume":"2014","author":"I Giusti","year":"2014","unstructured":"Giusti I, D\u2019Ascenzo S, Manc\u00f2 A, Di Stefano G, Di Francesco M, Rughetti A, et al. Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro. Biomed Res Int. 2014;2014(1):630870.","journal-title":"Biomed Res Int"},{"key":"9339_CR60","doi-asserted-by":"crossref","unstructured":"Zhang Z, Liu P, Xue X, Zhang Z, Wang L, Jiang Y, Zhang C, Zhou H, Lv S, Shen W, Yang S. The role of platelet-rich plasma in biomedicine: A comprehensive overview. iScience. 2025;28(2):111705.","DOI":"10.1016\/j.isci.2024.111705"},{"issue":"1","key":"9339_CR61","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0363546516643716","volume":"45","author":"J Fitzpatrick","year":"2017","unstructured":"Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226\u201333.","journal-title":"Am J Sports Med"},{"issue":"8","key":"9339_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082714","volume":"14","author":"A Corsini","year":"2025","unstructured":"Corsini A, Perticarini L, Palermi S, Bettinsoli P, Marchini A. Re-evaluating platelet-rich plasma dosing strategies in sports medicine: the role of the 10 billion platelet dose in optimizing therapeutic outcomes\u2014a narrative review. J Clin Med. 2025;14(8):2714.","journal-title":"J Clin Med"},{"key":"9339_CR63","doi-asserted-by":"crossref","unstructured":"Magalon J, Chateau AL, Bertrand B, Louis ML, Silvestre A, Giraudo L, Veran J, Sabatier F. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med. 2016;2(1):e000060.","DOI":"10.1136\/bmjsem-2015-000060"},{"key":"9339_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.reth.2024.07.004","volume":"26","author":"A Arita","year":"2024","unstructured":"Arita A, Tobita M. Adverse events related to platelet-rich plasma therapy and future issues to be resolved. Regen Ther. 2024;26:496\u2013501.","journal-title":"Regen Ther"},{"issue":"1","key":"9339_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s43054-024-00328-5","volume":"72","author":"E Levento\u011flu","year":"2024","unstructured":"Levento\u011flu E, B\u00f6nc\u00fco\u011flu E. Is platelet-rich plasma as safe as we think? A case report. Egypt Pediatr Assoc Gaz. 2024;72(1):88.","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"9339_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1204144","volume":"10","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Gong C, Peng X, Liu X, Su X, Tao X, et al. Efficacy and safety of platelet-rich plasma injections for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Front Med. 2023;10:1204144.","journal-title":"Front Med"},{"key":"9339_CR67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00403-019-01999-6","volume":"312","author":"AL Maisel-Campbell","year":"2020","unstructured":"Maisel-Campbell AL, Ismail A, Reynolds KA, Poon E, Serrano L, Grushchak S, et al. A systematic review of the safety and effectiveness of platelet-rich plasma (PRP) for skin aging. Arch Dermatol Res. 2020;312:301\u201315.","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"9339_CR68","doi-asserted-by":"publisher","DOI":"10.21037\/qims-24-176","volume":"14","author":"FR Santiago","year":"2024","unstructured":"Santiago FR, Gonz\u00e1lez CO, Cabrera BM, Ramos-Bossini AJ. Ultrasound-guided procedures in the musculoskeletal system: a narrative review with illustrative examples. Quant Imaging Med Surg. 2024;14(11):8028.","journal-title":"Quant Imaging Med Surg"},{"key":"9339_CR69","unstructured":"Haaz DI, Castro OR. Efficacy and safety of Intra-articular Platelet-Rich plasma (PRP) versus corticosteroid injections in the treatment of knee osteoarthritis: A systematic review of randomized clinical trials. Cureus. 2025;17(3):e80948.."},{"issue":"18","key":"9339_CR70","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.01446","volume":"102","author":"PV Rajan","year":"2020","unstructured":"Rajan PV, Ng MK, Klika A, Kamath AF, Muschler GF, Higuera CA, et al. The cost-effectiveness of platelet-rich plasma injections for knee osteoarthritis: a Markov decision analysis. J Bone Joint Surg. 2020;102(18):e104.","journal-title":"J Bone Joint Surg"},{"issue":"8","key":"9339_CR71","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1177\/0363546511404877","volume":"39","author":"S de Jonge","year":"2011","unstructured":"de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011;39(8):1623\u201330.","journal-title":"Am J Sports Med"},{"issue":"8","key":"9339_CR72","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1177\/0363546517743746","volume":"46","author":"X Chen","year":"2018","unstructured":"Chen X, Jones IA, Park C, Vangsness CT Jr. The efficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018;46(8):2020\u201332.","journal-title":"Am J Sports Med"},{"issue":"2","key":"9339_CR73","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v16.i2.102856","volume":"16","author":"LT Goulart","year":"2025","unstructured":"Goulart LT, Matsunaga FT, Belloti JC, Netto NA, Paim TS, Tamaoki MJ. Effectiveness of sub-acromial injections in rotator cuff injuries: a systematic review and meta-analysis. World J Orthop. 2025;16(2):102856.","journal-title":"World J Orthop"},{"key":"9339_CR74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10195-015-0376-5","volume":"17","author":"A Arirachakaran","year":"2016","unstructured":"Arirachakaran A, Sukthuayat A, Sisayanarane T, Laoratanavoraphong S, Kanchanatawan W, Kongtharvonskul J. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol. 2016;17:101\u201312.","journal-title":"J Orthop Traumatol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09339-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T16:01:52Z","timestamp":1765382512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-025-09339-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9339"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09339-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"- The study protocol was approved by the Institutional Review Board of Kafrelsheikh University (approval IRB No: KFSIRB200-396).- The trial was registered in the Pan African Clinical Trials Registry (PACTR202506613254896) on 10 June 2025, and is accessible at:\n                      \n                      .-\u00a0All subjects were informed and gave their voluntary, written informed consent.-\u00a0It is declared that all methods were carried out following relevant guidelines and regulations. It was performed according to the recommendations of Good Clinical Practice and the Declaration of Helsinki (2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1089"}}